Lecture 5 - Antibiotic Resistance Flashcards

1
Q

(T/F) It is common to be resistant to all antibiotics.

A

False!

It is rare to be resistant to ALL antibiotics.

A rare case: woman killed by a superbug (K. pneumoniae) resistant to all antibiotics available in US.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are antibiotics?

When are they called antibiotics?

A

Antibiotics are compounds produced by bacteria or plants (NATURAL) and chemists (SYNTHETIC) that kill or inhibit the growth of bacteria.

They are called antibiotics when we use them in the CLINIC to treat patients but they originated as ANTIMICROBIAL AGENTS (general term for compounds that kill or inhibit the growth of bacteria) in the env.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antibiotics are compounds that bacteria need to _____ themselves from.

Producers of antibiotics (trying to establish a _____) will have ______ mechanisms to protect themselves from what they are producing.

Other bacteria need to respond to these compounds by:

A

protect

niche; resistance

1) moving away
2) expressing resistance mechanisms
3) get eliminated from the env (ie get killed by the antibiotics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the general mechanism of antibiotics?

When does resistance occur?

A

Antibiotics have TARGETS in the bacterial cell. They interact with a target that is specific to a bacterial cell (cell wall, bacterial ribosome) and PREVENT PROPER FUNCTION resulting in either the death or growth inhibition of bacterial cell.

Resistance occurs when this interaction (between the antibiotic and the target) no longer occurs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Briefly describe how Fleming discovered penicillin in 1929.

A

Discovery was a chance observation, where contamination of a culture plate of staphylococci by mold led to the observation that the staph were lysing (zone of inhibition).

Penicillium notatum was the mold that produced penicilin.

Several years of study, a few publications and the discovery of other antibacterial agents led to use of penicillin in the clinic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

(T/F) Fleming warned of resistance of penicillin through overdosage.

A

False!

Fleming warned of resistance of penicillin through UNDERDOSAGE.

“It is not difficult to make microbes resistant to penicillin in the laboratory by exposing them to concentrations not sufficient to kill them, and the same thing has occasionally happened in the body.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What was the first antibiotic discovered? by who? to treat what?

A

Salvarasan was discovered by Paul Ehrlich to treat SYPHILIS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

(T/F) Resistance to penicillin was seen 10 years after it was put into widespread use in 1946.

A

False!

Resistance to penicillin was seen IMMEDIATELY after it was put into widespread use in 1946.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

There was an outbreak of shigella in 1953 with a strain that was resistant to three antibiotics.

What are these antibiotics?

A

streptomycin, chloramphenicol and tetracycline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some bacterial structures/processes targeted by antibiotics?

A

cell wall synthesis/integrity
cytoplasmic membrane
DNA replication
transcription
translation

*there are many antibiotics that target the same structures/processes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the four general antibiotic resistance mechanisms?

A

1) alteration of outer membrane (prevent an antibiotic from getting into the gram - cell)

2) up-regulation of drug efflux pumps (remove the antibiotic once it gets inside the cell)

3) alteration of the target (prevent the interaction between antibiotic and target -> prime mechanism that relies on mutations; primarily the target)

4) inactivation of the antibiotic (prevent the interaction between the antibiotic and target)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does antibiotic resistance arise?

A

1) mutation and selection - random mutations naturally occur at low frequency n antibiotic resistant mutants can be selected for by the environment

2) bacterial cells that produce antibiotics will have INTRINSIC (part of their genome - no mutations) resistance mechanisms (or else they will be killed by antibiotic that they produce)

these are sources of antibiotic resistance genes. THESE GENES CAN BE TRANSFERRED TO OTHER BACTERIA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do random mutations occur?

A

DNA polymerase makes mistakes (natural evolution) !!

the average mutation rate for bacterial genes is 10^8. these mutations can be selected for in the environment if they provide a growth advantage to the organism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do bacteria transfer resistance genes?

A

transformation (acquisition of DNA from the evn - released by other cells)

transduction (transfer of DNA via a virus - bacteriophage)

conjugation (cell-cell contact using a pilus to transfer DNA)

THIS IS VERY IMPORTANT - without these mechanisms, antibiotic resistance would be a much smaller issue!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The _____ often bacteria are exposed to antibiotics, the _____ likely they will be able to develop resistance to the antibiotic. (Is this entirely true?)

Antibiotics serve as a _______ _____ for bacteria that have a resistance mutation.

A

more

*this is true but it is a LIMITED VIEW - bacteria don’t have to be exposed to antibiotics to become resistant (intrinsic resistance)

selective agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

1) What are actinomycetes?

2) Where do most clinically relevant antibiotics originate from?

3) Why did D’Costa et al looked for resistance elements in soil dwelling bacteria?

A

1) Broad group of bacteria that form thread like filaments in the soil and are responsible for the distinctive scent of soil.

2) Most clinically relevant antibiotics originate from soil-dwelling actinomycetes.

3) These antibiotic producers harbour resistance elements for self-protection and these can be transferred to other bacteria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

1) What did D’Costa et al do to study the antibiotic resistome?

2) What did they find?

3) What are the conclusions from their study?

A

1) They went out to different sites around Hamilton, ON to collect soil samples and isolated actinomycetes from the soil. They created a library of 480 actinomycetes to screen against 21 antibiotics.

2) They found widespread resistance! These isolates were not exposed to these clinical antibiotics before!!! Every strain isolated from the soil was resistant to several drugs (average 7 or 8). Two strains were resistant to 15 out of the 21 drugs. They identified characterized resistance mechanisms and uncharacterized resistance mechanisms.

3) The study was done with env isolates. Potential exists that these mechanisms will be transferred to pathogenic bacteria (and that this has happened in the past) and we need to study the soil resistome and understand the resistance mechanisms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Define antibiotic resistome.

A

the group of all existing antibiotic resistance genes (known or unknown) in the world.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Does it make sense that there would be resistance in the absence of exposure to a particular clinically relevant antibiotic?

A

Yes! Intrinsic resistance mechanisms!!!

Producers need these genes to protect themselves and there can be transfer of these genes.

*bacteria don’t need to be exposed to clinically impt antibiotics to be resistant
*but when they are exposed, we will see resistance!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are some factors that can cause the development of resistance related to exposure to antibiotics?

A

1) Overuse of antibiotics (in humans and agriculture)

2) non-compliance (patients often stop taking the antibiotic too soon because the symptoms improve - allows resistant bacteria to proliferate)

3) natural exposure to antimicrobial agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Give examples of overuse of antibiotics in humans.

A
  • physicians often prescribe antibiotics for illnesses due to a VIRUS
  • individuals are put on long-term antibiotic treatment for conditions like acne, recurrent ear infections and UTIs (biofilm based; no response but other bacteria in body can develop resistance)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which statement is true?

1) Resistant strains spread pretty slowly.

2) The use of fluoroquinolone prophylaxis (giving antibiotics to prevent the development of an infection) increased between 1986-1993 and frequency of fluoroquinolone-resistant bacteria in cancer patients also increased.

A

2!

Resistant strains spread RAPIDLY.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Livestock producers feed healthy animals antibiotics to promote ______ and to compensate for ______ and _______ conditions found in the industry.

in 2001, it was estimated that __% of all antibiotics in the US are used to feed ______ pigs, poultry and beef cattle.

humans can become ______ by eating undercooked, contaminated meat (antibiotic resistant bacteria)

farm workers are continually in contact with ______ and ______-_______ bacteria

antibiotics and antibiotics-resistant bacteria enter the ________ through farm waste (flows into lakes, rivers, ground water)

A

growth; unsanitary; stressful

70%; healthy

infected

antibiotics; antibiotic-resistant

environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are two ways antibiotics are found in the environment and cause resistance?

A

1) Humans and animals excrete antibiotics that make their way into our environment where the antibiotics continue to exert their selective pressure.

2) Soil organisms produce antimicrobial agents NATURALLY, creating an environment for the selection of resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Differentiate acquired vs intrinsic resistance.

A

Acquired: resistance gene was not present in genome - it was acquired either through mutation and selection OR it was transferred from other bacteria.

Intrinsic: resistance gene is part of the genome - no mutations or DNA transfer occurred.

*resistance genes can be transferred to clinically relevant bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the 4 classes of antibiotics and what do they target?

A

1) b-lactams (target cell wall)

2) macrolides (target protein synthesis)

3) aminoglycosides (target protein synthesis)

4) quinolones (target DNA replication)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Briefly describe the structure of peptidoglycan.

A

Chains of NAG and NAM.

Lateral tetrapeptide chains fixed to NAM.

Chains crossed-linked through peptide interbridges = TRANSPEPTIDATION (through the action of penicillin-binding proteins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Briefly answer the following questions about b-lactams:

1) what are b-lactams?

2) give examples of b-lactams that are natural, have broad spectrum and have narrow spectrum

3) what is their mechanism of action?

A

1) beta-lactams are bactericidal (kill bacteria).

2)
natural: penicillin (work against gram + bacteria)

broad spectrum (work against both gram + and - bacteria): ampicillin, piperacillin, cephalosporins and carbapenems

narrow spectrum: methicillin

3) inhibit peptidoglycan synthesis by binding penicillin-binding proteins (transpeptidases). prevent the transpeptidation step.

*there are different classes within each 4 class of antibiotics. though they have the same target, they have different structures and functions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the 3 mechanisms of b-lactam resistance displayed in resistant clinical isolates?

A

1) loss or diminished expression of OM proteins (OM becomes less permeable and b-lactams cant get inside the cell)

2) alteration in penicillin binding proteins so that they have reduced affinity for b-lactams

3) production of b-lactamases (enzymes that hydrolyze the b-lactam ring) - major form of resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

1) What are b-lactamases?

2) How many have been identified?

3) Do b-lactamases provide resistance to just one specific b-lactam or multiple ones?

A

1) enzymes that hydrolyze the b-lactam ring. major resistance mechanism to b-lactams

2) over 2700 b-lactamases identified as of 2018

3) b-lactamases can mediate resistance to one specific b-lactams or more than one.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

1) How do MACROLIDES inhibit protein synthesis?

2) Give 2 examples of macrolides.

3) Are these bactericidal or bacteriostatic?

A

1) macrolides inhibit protein synthesis by binding to the 50S subunit of the ribosome.

2) erythromycin and azithromycin

3) mostly bacteriostatic (inhibits the growth of bacteria) but can be bactericidal in high concentrations

32
Q

What are the 2 mechanisms of macrolides resistance displayed in resistant clinical isolates?

A

1) active efflux
2) alteration of antibiotic binding site (on the ribosome) by METHYLATION

33
Q

1) How do AMINOGLYCOSIDES inhibit protein synthesis?

2) Give 2 examples of aminoglycosides.

3) Are these bactericidal or bacteriostatic?

A

1) aminoglycosides bind to 30s subunit (at INTERFACE of the 30s and 50s ribosomal units). they interfere with RNA translation by inducing ribosomal dissociation.

2) streptomycin, gentamycin, tobramycin

3) bactericidal (dissociate ribosomes)

34
Q

What are the 3 mechanisms of aminoglycosides resistance displayed in resistant clinical isolates?

A

1) decreased permeability of OM
2) active efflux
3) inactivation of aminoglycosides by the addition of an acyl or phosphate group

35
Q

1) How do QUINOLONES target bacteria?

2) Are these bactericidal or bacteriostatic?

3) How many generations are there?

A

1) they are inhibitors of nucleic acid synthesis! They interfere with DNA replication by targeting (and inhibiting) DNA gyrase or topoisomerase IV and tertiary negative supercoiling.

2) bactericidal

3) 3 generations of quinolones - spectrum defined by affinity of binding to either gyrase, topoisomerase or both

36
Q

Bacterial DNA is a ___ stranded, circular, _______ molecule; DNA replication requires systematic _________.

Replication fork introduces ______ _____.

DNA gyrase and topoisomerase ___ restore proper _________ of DNA.

A

double; supercoiled; unwinding

helical stress

conformation

37
Q

Match the quinolones to their generations.

1) 1st generation
2) 2nd generation
3) 2 and a half generation
4) 3rd generation

A) ciprofloxacin

B) 8 methoxy substitution - trovofloaxcin

C) nalidixic acid

D) levofloxacin

A

1st generation: nalidixic acid

2nd generation: ciprofloxacin

2 and a half generation: levofloxacin

3rd generation: 8 methoxy substitution - trovofloaxcin

38
Q

What are the 3 mechanisms of quinolones resistance displayed in resistant clinical isolates?

A

1) alteration of targets (topoisomerase IV and DNA gyrase)

2) efflux/permeability changes of the OM

3) plasmid base qnr (quinolone resistance) genes: encode protein that probably binds DNA gyrase and topoisomerase to protect them from quinolones

39
Q

What are the 4 antibiotic resistant pathogens of concerns?

A

1) methicillin resistant S. aureus (MRSA)

2) multidrug resistant P. aeruginosa

3) vancomycin-resistant enterococci (VRE)

4) extended spectrum b-lactamase (ESBL) producing organisms

40
Q

Which statement is false regarding MRSA?

1) Methicillin, a b-lactam, was introduced in 1959 and a MRSA was first identified in Britain in 1961.

2) MRSA is a major cause of community-acquired infections worldwide.

A

2!

MRSA is a major cause of nosocomial (hospital-acquired) infections worldwide! it is also now being found in communities.

41
Q

MSRA resistance is due to the presence of the ______ gene.

What does this gene encode?

A

mecA

mecA encodes a variant of a penicillin binding protein (PBP2a) that DOES NOT BIND b-lactams. thus, transpeptidation step will occur and cell wall remains intact.

42
Q

1) What is the SCCmec?

2) How many different types are there? How do they differ?

A

1) Staphylococcal Cassette Chromosome mec (SCCmec) is a MOBILE genetic element that has the mecA gene!

2) there are 11 major types of SCCmec (I-XI) that all have the mecA gene but differ in ADDITIONAL DRUG RESISTANCE GENES (eg. macrolide resistance and aminoglycoside resistance)

*mobile = primed to be transferred

43
Q

(T/F) It is uncommon to isolate P. aeruginosa that is resistant to several antibiotics in hospitals. Instead, they commonly display resistance to a single antibiotic.

A

False!

In the hospital, it is common to isolate P. aeruginosa that is resistant to several antibiotics; both due to acquired and intrinsic resistance.

44
Q

What is MIC?

A

minimum inhibitory concentration of an antibiotic

(lowest concentration of an antimicrobial agent that inhibits the visible growth of a microorganism)

45
Q

Briefly answer the following questions regarding RND efflux pump.

1) What is the function of RND efflux pumps?

2) What are the three main components of these pumps?

3) How many major pumps are found in P. aeruginosa? What do they do?

A

1) remove substrates from inside of bacterial cell

2)
inner membrane transporter
membrane fusion protein (MFP)
outer membrane protein (OMP)

3) There are 4 major RNA efflux pumps in P. aeruginosa. P. aeruginosa displays resistance to antibiotics by limiting its outer membrane permeability through these pumps, which can contribute to resistance via intrinsic or acquired means.

46
Q

(T/F) The different efflux pumps of P. aeruginosa all have different substrates.

A

False!

Different efflux pumps of P. aeruginosa have different or OVERLAPPING substrates.

47
Q

1) What are two examples of intrinsic resistance mechanisms involving efflux pumps in P. aeruginosa?

2) Which efflux pumps can undergo overexpression, contributing to acquired resistance in P. aeruginosa?

A

1) mexAB-OprM and mexXY-OprM

2) OVEREXPRESSION of MexAB-OprM, mexXY-OprM and mexCD-OprJ

48
Q

Describe how MexAB-OprM contributes to intrinsic and acquired resistance of P. aeruginosa.

A

Intrinsic resistance: MexAB-OprM is expressed constitutively in WT cells

Acquired resistance: OVEREXPRESSION of MexAB-OprM occurs when there is a mutation in the mexR gene (repressor of MexAB) resulting in an increase in resistance to fluoroquinolones

49
Q

Describe how MexXY-OprM contributes to intrinsic and acquired resistance of P. aeruginosa.

A

Intrinsic resistance: expression of MexXY-OprM is INDUCED by the presence of subinhibitory concentrations of antibiotics it pumps out

Acquired resistance: OVEREXPRESSION of MexXY-OprM has been observed commonly in isolates from CYSTIC FIBROSIS patient’s sputum. mexZ (negative regulator) is mutated in these strains and no longer works.

50
Q

(T/F) There are many biofilm-specific resistance mechanisms such as matrix and biofilm-specific gene expression.

A

True!

51
Q

Briefly answer the following questions regarding eDNA and antibiotic resistance:

1) where is eDNA found and how does it get there?

2) what does it do? how?

3) what does low magnesium result in?

A

1) eDNA is found in biofilm matrix due to active release of DNA from cells, as well as death of cells.

2) ANIONIC nature allows eDNA to CHELATE cations like magnesium ions, resulting in low Mg2+ in the matrix.

3) low Mg2+ results in an ALTERATION IN LPS that further results in LOWER OUTER MEMBRANE PERMEABILITY to certain antimicrobial agents.

52
Q

1) What was the hypothesis Dr. Mah was testing?

2) How did she approach her hypothesis? What was the goal?

A

Dr. Mah wanted to test if there are genes important for biofilm-specific antibiotic resistance.

Hypothesis: there are genes that are expressed only in biofilms whose gene products protect biofilm cells from antibiotics.

Approach: since it was unclear why biofilm cells are more resistant to antibiotics, they decided to take a GENETIC APPROACH to by screening a collection of PA mutants for the loss of biofilm-specific resistance.

Goal: identify genes that are important for biofilm specific antibiotic resistance.

53
Q

Briefly describe the genetic screen used by Dr. Mah to identify genes that are important for biofilm specific antibiotic resistance.

A

Screened ~10,000 random TRANSPOSON-INSERTION mutants.

Let them form BIOFILMS first and then exposed them to 50ug/mL tobramycin (WT biofilm can survive 400ug/mL).

Identified 43 candidates and analyzed candidates in several secondary screens (growth, biofilm formation, planktonic antibiotics resistance).

54
Q

Dr. Mah successfully isolated 6 mutants from her genetic screen.

What were the 4 properties of the mutants she identified?

What do these mutants represent?

A

1) grow as well as the WT
2) have same planktonic resistance level as the WT
3) make a biofilm
4) more susceptible to Tb compared to the WT biofilm

These mutants represent genes whose WILD TYPE function is important for antibiotic resistance in biofilms (the mutants are more sensitive to antibiotics).

This is another example of INTRINSIC antibiotic resistance!

55
Q

Once Dr. Mah detected genes important for antibiotic resistance in biofilms through her genetic screen.

She wanted to know why these genes are important for antibiotic resistance in biofilms.

What is her approach in answering this question?

A
  • confirm observation
  • construct deletion mutants
  • determine mechanism of resistance by analyzing WT function of gene product and relating back to resistance
56
Q

Briefly answer the questions regarding confirmation of biofilm-specific antibiotic selectivity phenotype of mutant 1:

1) What was the minimal bactericidal concentration (MBC) for both wild-type (WT) and mutant bacteria in planktonic form?

2) How did the mutant bacteria’s sensitivity to the antibiotic change compared to the wild-type in biofilm?

3) How much greater dose of MBC was needed for the WT biofilm compared to planktonic bacteria?

4) What was the difference in MBC dose needed for the mutant biofilm compared to planktonic bacteria?

A

1) The MBC for both WT and mutant bacteria in planktonic form was the SAME (0.008) - this indicates that planktonic bacteria do not require mutated gene for antibiotic resistance.

2) The mutant bacteria in biofilm were more sensitive to the antibiotic, requiring a lower concentration (0.025) compared to the WT (0.40).

3) The WT biofilm needed a 50 times greater dose of MBC compared to planktonic bacteria.

4) The mutant biofilm needed a 3 times greater dose of MBC compared to planktonic bacteria.

*example of confirming the phenotype

57
Q

Mutant 1 of Dr. Mah’s research had a ________ insertion in a predicted __________.

This gene is 58% identical to the ____ gene from ________.

___ and ___ are required for synthesis of cyclic b-(1-3), (1-6) glucans which are cyclic sugar molecules made of _______.

A

Tn5 (transposon); glycosyltransferase

ndvB gene; B. japnoicum (bacterium important for nitrogen fixation)

ndvB; ndvC; glucose

58
Q

ndvB is highly expressed in _____ cells but not in ______ cells.

A

biofilm; planktonic

59
Q

What are the 3 PREDICTED roles of ndvB-derived glucans in Biofilm-specific Resistance?

A

1) biofilm architecture

2) sequestration

3) signalling

*based on literature and logic
*these were then tested to see ndvb had an effect on them

60
Q

(T/F) ndvB mutant (no ndvB) had a significantly effect on biofilm architecture as predicted by literature.

A

False!

ndvB mutant had NO EFFECT on biofilm architecture.

61
Q

What made Dr. Mah think that P. aeruginosa cyclic glucans and Tb may interact?

A

Cyclodextrin has a similar structure to the cyclic b-(1-3), (1-6) glucans that are synthesized by ndvB (highly expressed in biofilms) and ndvC.

The barrel of cyclodextrin can accommodate hydrophobic residues of chemical structures.

62
Q

Describe the in vitro interaction assay used to determine if Tb flows through the column without PA cyclic glucans.

A

Tb was flown through a column and was subjected to three water washes, as well as washes with 25% and 50% acetonitrile.

Then, an bioassay on lawn of E.coli was performed using the fractions generated from the column

The zone of clearing indicates which fraction the Tb is in.

Flow through of Tb and water wash 1 had zone of clearing. Therefore, it was determined that tb flows through the column in the absence of pre-loaded PA cyclic glucans.

62
Q

Using gel filtration chromatography,
they were able to purify glucans from Wt and ΔndvB.

What did they confirm with this?

A

They confirmed that the WT produced material that was composed of glucose.

They also confirmed that ΔndvB did not produce glucans (and thus is defective in glucan synthesis)!

63
Q

Describe the assay that determined that purified PA cyclic glucans interact with Tb in vitro.

A

pre-loaded glucans (isolated by gel filtration) onto column and then added Tb.

They collected fractions from the flow through, the 3 water washes and 2 acetonitrile washes (25% and 50%).

Then, a bioassay on lawn of E.coli was performed.

WT glucan had zone of clearing in Ft, water wash 1, and 25% acetonitrile !!

ΔndvB glucan had zone of clearing in FT and water wash 1 (as expected since it has no glucans - negative control).

64
Q

Describe the model for biofilm antibiotic resistance of cyclic glucans.

A

Tb wants to get into the cytoplasm.

ndvB-derived periplasmic glucans interact with Tb and prevent Tb from reaching target in cytoplasm.

Tb is are permanently stuck in periplasm or slowed down which gives the bacterium enough time to express other antibiotic resistance genes.

65
Q

(T/F) There is another function of ndvB derived glucans in biofilm specific antibiotic resistance besides sequesteration.

A

Yes!

In signalling!

66
Q

Which statement is false regarding ndvB?

1) it is required to produce glucans

2) it is important for biofilm specific resistance to a subset of antibiotics

3) it is equally expressed in biofilms and planktonic celsl

A

3!

it is MORE highly expressed in biofilms!

67
Q

How do glucans function in biofilm specific resistance?

A

by preventing access of antibiotics to targets in the cell AND affecting the expression of genes important for protecting cells against the cytotoxic effect of ROS.

*natural function of glucans: protect PA from toxic compounds present in the env?

68
Q

Biofilm specific antibiotic resistance is due to _______ _____ resistant mechanisms and likely evolved to protect biofilms from the ________ compounds in the environment.

A

multiple intrinsic (not due to mutations!)

antimicrobial

69
Q

Which statement is false?

1) incidence of antibiotic resistant bacteria is on the rise

2) biofilm based infections are also on the rise and these infections are notoriously difficult to eradicate with traditional antibiotic treatment

3) drug companies are developing new antibiotics because they’re very profitable

A

3!

drug companies are NOT developing new antibiotics because it is too expensive.

70
Q

How can the following entities contribute to addressing antibiotic resistance:

1) Government

2) Industry

3) Individuals

4) Scientists

A

1) Governments need to recognize the impt of offering incentives for antibiotic research.

2) Industry needs to recognize that antibiotics should not be used for animals unless to treat infection

3) Individuals need to recognize the importance of proper use of antibiotics and proper disposable of them

4) Scientists need to identify new drug targets (biofilm-specific resistance genes + virulence factors) and new antimicrobial agents from the environment (from plants + phages)

71
Q

How does targeting virulence factors differ from traditional antibiotics to treat bacterial infections?

How can we target virulence factors?

A

Traditional antibiotics kill bacteria or inhibit their growth (act as a selective pressure forcing the bacteria to become resistant).

Preventing virulence (ability of pathogen to cause disease) would “disarm” the bacteria and the bacteria would eventually be cleared by the immune system

We can target virulence factors through:
- inhibition of toxin function
- inhibition of secretion
- controlling regulation of virulence gene expression
- inhibition of adhesion

72
Q

Maggots successfully treated an ______ contaminated foot ulcers of diabetic patients.

The infection was cleared from ___ out of 13 patients.

Maggots promote wound healing by removing ____ tissue and secreting a new type of antimicrobial agent (against MRSA, E.coli and C. difficile) called ________.

A

MRSA

12

dead; SERATICIN

73
Q

(T/F) Gram negative predatory bacterium (B. bacteriovorus) found in wet, aerobic environments can reduce E. coli biofilm.

A

True!

They attack other gram negative cells by entering their periplasm, multiplying and bursting the cell envelope.

74
Q

What are bacteriophages?

Where are they used extensively?

A

Bacteriophages are viruses that can lyse and kill bacteria.

Phage therapy has been used extensively in eastern European and former Soviet Union countries but never gained popularity in western countries.

Widespread resistance to antibiotics has led to renewed interest bacteriophages.